Top Manufacturing Companies in Dublin (53)
ICON is the global leader in construction technology, developing robotics, intelligent software systems, and advanced materials that are changing the way the world builds on Earth and beyond. The way we build for the future must be different than the way we build today. Through advanced robotics and automated construction systems, we are reimagining what it means to build. ICON is...
ICON's Top Stability & Growth Strengths
Strategic Partnerships: Colleagues are often seen aligning behind marquee partners and institutions, including Lennar for large community delivery and U.S. government agencies for defense and space programs. Feedback suggests these relationships create repeatable demand signals and validation pathways that support scaling.
Investor Backing & Capital Strength: Capital support is evidenced by continued growth fundraising (e.g., a $56M raise in 2025) and references to substantial cumulative funding, which underwrites product development and deployment capacity. Feedback suggests this funding continuity buffers the company through a volatile, early-stage market.
Innovation-Driven Growth: Product progress is framed around multi-story capable robotics, lower-carbon printable materials, and a digital/AI design catalog intended to standardize and scale delivery. Feedback suggests the roadmap focuses on moving from bespoke projects toward more repeatable, platform-like execution.
Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of patients with underserved conditions. As an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company’s patient-centric products span...
CroíValve is an early-stage medical device company developing a unique transcatheter device to repair the tricuspid valve
Eco Urban Scooters and ZEUS Scooters is an Irish owned and operated electric scooter sharing provider. We strive to reduce congestion on city streets and bring sensible urban commuting to you
Ipsen is a French leading global mid-size biopharmaceutical company headquartered in Paris, France focusing its efforts where unmet medical needs are greatest. Ipsen develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Rare Disease and Neuroscience. We have over 5000 employees worldwide and our medicines are registered in more than 100 countries, with direct commercial presence in...
Ipsen's Top Stability & Growth Strengths
Strong Revenue Growth: Reported results show double-digit growth at constant exchange rates in 2024 and 2025 with an accelerated start in Q1 2026, and guidance indicates continued expansion in 2026. This momentum spans all three therapeutic areas rather than a single product.
Profitability: Disclosures highlight expanding core operating margins above the mid-30s and rising core operating income. Guidance continues to target strong margins alongside growth.
Diversified Revenue Streams: Recent updates indicate contributions from Oncology, Rare Disease, and Neuroscience, with products excluding Somatuline growing strongly and rare disease accelerating. Strategic acquisitions and partnerships have broadened the base beyond any single legacy brand.
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development...
ICON plc's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is positioned as a top-tier global CRO with significant scale and a broad geographic footprint, supported by a major acquisition that strengthened its competitive standing. Operational activity indicators and industry recognition are presented as reinforcing its ability to win and execute large, complex trials.
Profitability: Earnings and operating profit metrics are described as improving in 2024, with increases in GAAP net income, adjusted earnings per share, and adjusted EBITDA. These results suggest the business maintained solid margin performance even as quarterly revenue fluctuated.
Resilient & Sustainable Growth: A large backlog and a book-to-bill above 1.0 in 2024 are cited as providing multi-year revenue visibility and demand coverage. Continued backlog levels into 2025 are described as a stabilizing factor despite a softer near-term revenue trajectory.
Schneider Electric is your energy technology partner. We lead the convergence of electrification, automation, and digital intelligence to make the New Energy Landscape possible. Through platforms like EcoStruxure, we enable buildings, data centers, factories, infrastructure, and grids to operate as open, software-defined systems with intelligence built in at every level. We go beyond connectivity - simplifying complexity and unlocking the...
Schneider Electric's Top Stability & Growth Strengths
Strong Revenue Growth: Feedback suggests Schneider delivered record annual results, sustained strong organic growth into early 2026, and holds a sizable backlog that provides good visibility. Company commentary ties momentum to Energy Management and data‑center‑related systems.
Strong Market Position & Advantage: Feedback suggests the firm is widely viewed as a leader across energy management, data center power distribution, and grid/digital platforms, reinforced by independent leaderboards and repeated sustainability accolades. Competitive comparisons also cite strengths in service quality, integration, and overall culture versus key peers.
Market Expansion: Feedback suggests the company is actively investing and hiring, with major U.S. capacity expansions and thousands of open roles globally targeted at AI, data centers, and grid modernization. North America shows particularly strong traction alongside growth in other regions.
Applied Materials is the leader in materials engineering solutions used to produce virtually every new chip and advanced display in the world. Our expertise in modifying materials at atomic levels and on an industrial scale enables customers to transform possibilities into reality. At Applied Materials, our innovations make possible a better future.
Applied Materials's Top Stability & Growth Strengths
Strong Market Position & Advantage: Applied Materials is widely characterized as a top-tier leader in semiconductor equipment with a broad, diversified front-end portfolio and leadership in critical process areas like deposition. Its global reach and participation across most wafer-fab steps reinforce a durable competitive position.
Strong Revenue Growth: Recent results highlight record quarterly and annual revenue with guidance pointing to further acceleration into 2026. Consistent outperformance versus expectations and raised outlooks indicate building momentum.
Innovation-Driven Growth: Growth is propelled by exposure to AI, leading-edge logic, DRAM, and advanced packaging, with management projecting rapid expansion in these areas through 2026. Significant R&D investment and new capabilities in high-bandwidth memory and advanced packaging support this trajectory.
Integra LifeSciences, a world leader in medical technology with headquarters in Princeton, New Jersey, was founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has expanded its base regenerative technology product portfolio to include surgical instruments, neurosurgical products and advanced wound care products, through global acquisitions and development...
Cubic³ provides advanced software-defined vehicle (SDV) solutions in over 200 countries and territories around the world. Our ‘powerfully smart connectivity’ enables leading automotive, agriculture and transportation OEMs to deliver innovative new services and fully compliant in-vehicle experiences that their customers desire, regardless of local market requirements.
Pilot Photonics Ltd offers unique optical comb source subsystems that it develops as a platform technology applicable to many markets including communication, spectroscopy, sensing, and metrology. The company has deep IPR around the generation and application of optical combs which it couples with a powerful capability in photonic integration to produce the world's smallest and most versatile comb sources. Pilot...
At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal...
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments...
BioMarin Pharmaceutical Inc.'s Top Stability & Growth Strengths
Strong Revenue Growth: Results show double‑digit revenue growth in 2025, with acceleration in Q4 driven by Voxzogo uptake and steady enzyme therapies across 55 markets. 2026 guidance points to a higher revenue range, indicating continued expansion.
Profitability: Disclosures highlight strong profitability with $828 million in 2025 operating cash flow and a targeted ~40% non‑GAAP operating margin for 2026 (excluding Amicus). Non‑GAAP EPS guidance of $4.95–$5.15 further signals operating leverage.
Diversified Revenue Streams: The portfolio spans multiple enzyme therapies and the achondroplasia franchise, and the pending Amicus acquisition would add Galafold and Pombiliti + Opfolda to diversify revenues from mid‑2026 onward. Enzyme therapies collectively grew in 2025, supporting breadth beyond a single asset.
Plasma Bound provides a step-change technology, termed Controlled Polymer Ablation (CPA), which facilitates the structural adhesive joining of lightweight materials, namely carbon and glass fibre reinforced composites. CPA technology will accelerate the use of these lightweight composite materials into multi-material structural assemblies, by enabling reliable adhesive joining which is stronger than the composite structures themselves. The technology will satisfy the...
Atlas is a leading designer and manufacturer of autonomous UAV systems for professional use-cases, that works with a dominant defense, security, and infrastructure institutions in the U.S., the E.U., and Asia. Founded in the EU in 2015 by Aerospace and Robotics professionals with a vision to disrupt the UAV sphere, Atlas utilizes its proprietary and cost-effective technology to provides defense...
Rejuvant is a science-backed, purpose-driven longevity wellness brand elevating functionally innovative ingredients into a proprietary patent pending compound to enhance healthspan. Its core mission is to rise up against and reverse the aging process, using science backed data, engaging in consumer education and manufacturing Rejuvant through a slow release mechanism with the highest standards of purity, potency and transparency. Rejuvant...
NIBCO is a leading manufacturer and provider of flow control solutions, including valves, piping, and fittings, for residential, commercial, industrial, and municipal markets.
Perrigo Company plc, is a global consumer self-care company. Our vision is: To make lives better by bringing "Quality, Affordable Self-Care Products" that consumers trust everywhere they are sold. Founded in 1887 as a packager of home remedies, Perrigo has transformed to a self-company which enables the empowered consumer to treat conditions that can be self-managed. Perrigo is the world's largest...
Analog Devices, Inc. (NASDAQ: ADI) operates at the center of the modern digital economy, converting real-world phenomena into actionable insight with its comprehensive suite of analog and mixed signal, power management, radio frequency (RF), and digital and sensor technologies. ADI serves 125,000 customers worldwide with more than 75,000 products in the industrial, communications, automotive, and consumer markets. ADI is headquartered...
Analog Devices's Top Stability & Growth Strengths
Strong Market Position & Advantage: Analog Devices is positioned as a top-tier analog and mixed-signal semiconductor provider with leadership in key niches like data converters and a “premium position” in complex, high-performance analog. Its design-in “stickiness” in long-lifecycle systems is described as supporting predictable, long-term revenue.
Strong Revenue Growth: Recent results show a rebound and acceleration, including fiscal 2025 revenue growth versus 2024 and strong year-over-year growth in the most recent quarter with higher near-term revenue guidance. Forward-looking expectations also indicate continued expansion over the next several years.
Healthy Cash Flow: Cash generation is described as robust, with strong operating and free cash flow enabling sizable shareholder returns through dividends and repurchases. Ongoing dividend increases are presented as consistent with confidence in durable cash generation.
Diageo's official LinkedIn account. We're a global leader in premium drinks, across spirits and beer, a business built on the principles and foundations laid by the giants of the industry. With over 200 brands sold in 180 countries, our portfolio has remarkable breadth. From centuries-old names to exciting new entrants, and global giants to local legends, we're building the very best...
Diageo's Top Stability & Growth Strengths
Strong Market Position & Advantage: Diageo is consistently depicted as the global leader in international spirits, with category leadership in Scotch and tequila and Johnnie Walker’s category-topping status anchoring that edge. Scale and global reach provide durable share and pricing power even through cycles.
Strong Brand Reputation: Iconic, globally recognized brands such as Johnnie Walker, Guinness, Smirnoff, and Don Julio, alongside independent brand‑valuation mentions, support resilient brand equity. Company materials emphasize a brand‑led strategy that sustains pricing and share through continued investment.
Healthy Cash Flow: Management targeted roughly $3 billion of free cash flow for FY26 despite softer top‑line trends. An accelerated multi‑year cost‑savings program is intended to support cash generation and financial flexibility.
